Oxidative metabolism of energy substrates by preimplantation mouse embryos in the presence of platelet-activating factor
- 1 May 1990
- journal article
- research article
- Published by Bioscientifica in Reproduction
- Vol. 89 (1) , 301-307
- https://doi.org/10.1530/jrf.0.0890301
Abstract
The effects of exogenous platelet-activating factor (PAF, 0.0186-18.6 .mu.M) on the production of CO2 from [U-14C]glucose and [1-14C]lactate by mouse embryos in vitro were investigated. Two-cell embryos displayed significant dose-dependent responses for both energy substrates. The maximal response was observed at 9.3 .mu.M-PAF for glucose metabolism and 1.86 .mu.M-PAF for lactate with increases of 62% and 18%, respectively, over control treatments. After culture from the 2-cell stage for 72 h in the presence of PAF, the resulting blastocysts exhibited a significant dose-dependent increase in metabolism of lactate. It was also apparent that such embryos were not desensitized to PAF as demonstrated by a further enhancement of the metabolic response after re-exposure to PAF. The specificity of action of PAF was confirmed by the absence of any effect on the oxidative metabolism of glucose by lyso-PAF (a catabolite of PAF) over a concentration range of 0.0202-20.2 .mu.M and by the demonstration that SRI 63-441 (a PAF-receptor antagonist) significantly reduced the amount of CO2 produced from glucose in response to 9.3 .mu.M-PAF and abolished the effect on lactate metabolism in response to 1.86 .mu.M-PAF. These results demonstrate a specific, direct influence of exogenous PAF on the oxidative metabolism of glucose and lactate by the preimplantation mouse embryo and suggest an autocrine role for embryo-derived PAF in early pregnancy.This publication has 5 references indexed in Scilit:
- Antagonists of embryo-derived platelet-activating factor act by inhibiting the ability of the mouse embryo to implantReproduction, 1990
- INHIBITION OF PAF-INDUCED SYSTEMIC RESPONSES IN THE RAT, GUINEA-PIG, DOG AND PRIMATE BY THE RECEPTOR ANTAGONIST SRI 63-4411986
- CYTO-TOXICITY OF PLATELET ACTIVATING FACTOR AND RELATED ALKYL-PHOSPHOLIPID ANALOGS IN HUMAN-LEUKEMIA CELLS, POLYMORPHONUCLEAR NEUTROPHILS, AND SKIN FIBROBLASTS1984
- Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).The Journal of Immunology, 1981
- Antihypertensive activity of an alkyl ether analog of phosphatidylcholineBiochemical and Biophysical Research Communications, 1979